ATE528651T1 - Diagnoseverfahren für pulmonale arterielle hypertonie - Google Patents

Diagnoseverfahren für pulmonale arterielle hypertonie

Info

Publication number
ATE528651T1
ATE528651T1 AT09742310T AT09742310T ATE528651T1 AT E528651 T1 ATE528651 T1 AT E528651T1 AT 09742310 T AT09742310 T AT 09742310T AT 09742310 T AT09742310 T AT 09742310T AT E528651 T1 ATE528651 T1 AT E528651T1
Authority
AT
Austria
Prior art keywords
arterial hypertension
pulmonary arterial
diagnostic methods
paht
tenascin
Prior art date
Application number
AT09742310T
Other languages
English (en)
Inventor
Luc Mouthon
Marc Humbert
Mathieu Tamby
Original Assignee
Assist Publ Hopitaux De Paris
Univ Paris Descartes
Univ Paris Sud 11
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publ Hopitaux De Paris, Univ Paris Descartes, Univ Paris Sud 11 filed Critical Assist Publ Hopitaux De Paris
Application granted granted Critical
Publication of ATE528651T1 publication Critical patent/ATE528651T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
AT09742310T 2008-04-11 2009-04-10 Diagnoseverfahren für pulmonale arterielle hypertonie ATE528651T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0852459A FR2930036B1 (fr) 2008-04-11 2008-04-11 Procede de diagnostic d'une hypertension arterielle pulmonaire.
PCT/FR2009/050661 WO2009136112A1 (fr) 2008-04-11 2009-04-10 Procede de diagnostic d'une hypertension arterielle pulmonaire

Publications (1)

Publication Number Publication Date
ATE528651T1 true ATE528651T1 (de) 2011-10-15

Family

ID=39876870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09742310T ATE528651T1 (de) 2008-04-11 2009-04-10 Diagnoseverfahren für pulmonale arterielle hypertonie

Country Status (10)

Country Link
US (1) US8609356B2 (de)
EP (1) EP2274623B1 (de)
JP (1) JP5518836B2 (de)
AT (1) ATE528651T1 (de)
CA (1) CA2721049C (de)
DK (1) DK2274623T3 (de)
ES (1) ES2376459T3 (de)
FR (1) FR2930036B1 (de)
PT (1) PT2274623E (de)
WO (1) WO2009136112A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2964314B1 (fr) * 2010-09-02 2013-06-28 Assist Publ Hopitaux De Paris Score predictif du risque de survenue d'hypertension arterielle pulmonaire chez des patients atteints de sclerodermie systemique.
KR20140109956A (ko) * 2011-12-12 2014-09-16 아이시스 이노베이션 리미티드 테나신-c 및 류마티스 관절염에서의 이의 용도
WO2014067965A1 (en) * 2012-10-29 2014-05-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods of predicting or diagnosing a pulmonary arterial hypertension
US9603890B2 (en) 2012-12-03 2017-03-28 Vascular Biosciences Methods for increasing the selective efficacy of gene therapy using CAR peptide and heparan-sulfate mediated macropinocytosis
JP6116938B2 (ja) * 2013-02-28 2017-04-19 学校法人順天堂 新規な肺高血圧症のマーカー

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880750A (en) * 1987-07-09 1989-11-14 Miragen, Inc. Individual-specific antibody identification methods
WO1999043308A2 (en) * 1998-02-27 1999-09-02 Marlene Rabinovitch Treating pulmonary hypertension through tenascin suppression and elastase inhibition
DE19939575C1 (de) * 1999-08-20 2001-08-02 Orgentec Diagnostika Gmbh Verfahren zur Diagnose von Sjögren-Syndrom
JP3646159B2 (ja) * 2001-02-08 2005-05-11 国立大学法人三重大学 抗テネイシンｃモノクローナル抗体及び当該抗体を産生するハイブリドーマ
US6989276B2 (en) * 2001-05-10 2006-01-24 Battelle Energy Alliance, Llc Rapid classification of biological components
JP4488746B2 (ja) * 2002-02-26 2010-06-23 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 抗−ヒトテネイシンモノクローナル抗体
WO2005009366A2 (en) * 2003-07-24 2005-02-03 Cornell Research Foundation, Inc. Restoring vascular function
WO2007123976A2 (en) * 2006-04-18 2007-11-01 The Board Of Trustees Of The Leland Stanford Junior University Antibody profiling for determination of patient responsiveness
WO2009123730A1 (en) * 2008-04-02 2009-10-08 The Trustees Of The University Of Pennsylvania Methods for diagnosis and prognosis of pulmonary hypertension

Also Published As

Publication number Publication date
JP5518836B2 (ja) 2014-06-11
PT2274623E (pt) 2012-01-05
CA2721049C (fr) 2016-02-09
EP2274623B1 (de) 2011-10-12
US8609356B2 (en) 2013-12-17
WO2009136112A1 (fr) 2009-11-12
CA2721049A1 (fr) 2009-11-12
FR2930036A1 (fr) 2009-10-16
FR2930036B1 (fr) 2010-05-07
ES2376459T3 (es) 2012-03-14
DK2274623T3 (da) 2012-01-09
JP2011516876A (ja) 2011-05-26
EP2274623A1 (de) 2011-01-19
US20110033876A1 (en) 2011-02-10

Similar Documents

Publication Publication Date Title
HK1202154A1 (en) Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
ATE554389T1 (de) Apex als marker für lungenkrebs
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
EP2471064A4 (de) Verfahren und system zur rekonstruktion von sprache aus einem eingangssignal mit geflüsterten teilen
WO2007117444A3 (en) Protein detection by aptamers
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
PH12014500650A1 (en) Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage
HK1202157A1 (en) Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
WO2010046443A3 (en) Methods for detection and diagnosis of a bone or cartilage disorder
ATE474228T1 (de) Reagenz für hämoglobinabbau
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
NZ594772A (en) Diagnosis and prognosis of renal injury and renal failure using vitamin k dependent protein c
ATE528651T1 (de) Diagnoseverfahren für pulmonale arterielle hypertonie
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
RU2013138721A (ru) Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
PL2057467T3 (pl) Sposób diagnozowania choroby z udziałem przeciwciała przeciwko receptorowi AT1
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
WO2010144553A3 (en) Methods for diagnosing blood vessel reocclusion
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
DE602006021038D1 (de) Verfahren zur diagnose eines ovarialkarzinoms
WO2008145701A9 (en) Method for predicting the outcome of a critically ill patient
WO2015006657A8 (en) Method for the diagnosis and prognosis of cancer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2274623

Country of ref document: EP